Di Federico, A.; De Giglio, A.; Parisi, C.; Gelsomino, F., STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?, «EUROPEAN JOURNAL OF CANCER», 2021, 157, pp. 108 - 113 [Scientific article]
De Giglio, A.; Di Federico, A.; Nuvola, G.; Deiana, C.; Gelsomino, F., The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines), «CURRENT ONCOLOGY REPORTS», 2021, 23, pp. 1 - 15 [Scientific article]
Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A., Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2020, 156, Article number: 103119 , pp. 1 - 18 [Scientific article]
Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppioni E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A., Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience, «LUNG CANCER», 2020, 149, pp. 5 - 9 [Scientific article]
Di Federico A.; Nuvola G.; Sisi M.; Lenzi B.; Nobili E.; Campana D., Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?, «ANTI-CANCER DRUGS», 2020, 31, pp. 1103 - 1105 [Scientific article]
Gelsomino, F.; Di Federico, A.; Filippini, D. M.; Dall'Olio, F. G.; Lamberti, G.; Sperandi, F.; Balacchi, C.; Brocchi, S.; Ardizzoni, A., Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report, «CLINICAL LUNG CANCER», 2020, 21, pp. E45 - E48 [Scientific article]
Mariacristina Di Marco, Riccardo Carloni, Stefania De Lorenzo, Cristina Mosconi, Andrea Palloni, Elisa Grassi, Daria Maria Filippini, Angela Dalia Ricci, Alessandro Rizzo, Alessandro Di Federico, Donatella Santini, Daniela Turchetti, Claudio Ricci, Carlo Ingaldi, Laura Alberici, Francesco Minni, Rita Golfieri, Giovanni Brandi, Riccardo Casadei, Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report, «WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY», 2020, 12, pp. 1456 - 1463 [Scientific article]Open Access
Lamberti G.; Andrini E.; Sisi M.; Di Federico A.; Ricciuti B., Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: Rationale and clinical implication, «FUTURE ONCOLOGY», 2020, 16, pp. 1751 - 1766 [Scientific article]
Di Federico A.; Filippini D.M.; Dall'Olio F.G.; Conci N.; Minari R.; Tiseo M.; Ardizzoni A., The EGFR exon 19 mutant L747-A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma—letter, «CLINICAL CANCER RESEARCH», 2020, 26, pp. 518 - 519 [Scientific article]
